Acutus Medical (AFIB) Stock Price, News & Analysis

Company Overview

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Key Stats

• Today's Range: $0.06 to $0.06
• 50-Day Range: $0.03 to $0.19
• 52-Week Range: $0.03 to $0.43
• Volume: 93,910 shs
• Average Volume: 840,244 shs
• Market Capitalization: $1.87 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AFIB Stock Analysis - Frequently Asked Questions

How have AFIB shares performed this year?

Acutus Medical's stock was trading at $0.2019 at the start of the year. Since then, AFIB shares have decreased by 68.8% and is now trading at $0.0630.
View the best growth stocks for 2024 here.

How were Acutus Medical's earnings last quarter?

Acutus Medical, Inc. (NASDAQ:AFIB) announced its earnings results on Thursday, November, 11th. The company reported ($0.94) EPS for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The business had revenue of $4.60 million for the quarter, compared to analysts' expectations of $6.02 million. Acutus Medical had a negative net margin of 272.74% and a negative trailing twelve-month return on equity of 311.64%.

Does Acutus Medical have any subsidiaries?

The following companies are subsidiaries of Acutus Medical: Acutus Medical N.V..

When did Acutus Medical IPO?

Acutus Medical (AFIB) raised $126 million in an IPO on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

How do I buy shares of Acutus Medical?

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Enterprise Products Partners (EPD), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), NextEra Energy Partners (NEP), PayPal (PYPL) and Rio Tinto Group (RIO).

Company Calendar

• Last Earnings: 11/11/2021
• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AFIB
• CUSIP: N/A
• CIK: 1522860
• Web: www.acutusmedical.com
• Phone: 442-232-6080
• Fax: 442-232-6081
• Employees: 340
• Year Founded: 2011

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-81,660,000.00
• Net Margins: -272.74%
• Pretax Margin: -30.32%
• Return on Equity: -311.64%
• Return on Assets: -11.57%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.85
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: $7.16 million
• Price / Sales: 0.25
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.35) per share
• Price / Book: -0.17

Miscellaneous

• Outstanding Shares: 29,780,000
• Free Float: 28,228,000
• Market Cap: $1.79 million
• Optionable: Optionable
• Beta: N/A